Nobuharu Fujiwara

Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome

Tsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara et al. · Clinical Biochemistry · 2011 · 78 citations

Acute Lung Injury, Inflammation, Respiratory Distress Syndrome (Pulmonary Critical Care) +8

Positive association of serum levels of advanced glycation end products and high mobility group box–1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients

Tsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara et al. · Metabolism · 2009 · 54 citations

Metabolic Syndrome, Urology, Renal Disease +14

Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation

Tsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara et al. · Metabolism · 2010 · 52 citations

Glomerular Disease, Inflammation, Urology +9

Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock

Tsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara et al. · Pharmacological Research · 2009 · 46 citations

Inflammation, Immunology, Inflammatory Marker +7

Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner

Tsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara et al. · Pharmacological Research · 2009 · 44 citations

Metabolic Syndrome, Urology, Renal Function +13